See also this year's filing and all EDGAR filings for this company.
PDF Report 0001510487_2020_Principia_Biopharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001510487')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001510487, Principia Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 319,745,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,687,000 |
| 3 | remainder_Assets | 53,304,000 |
| 4 | LiabilitiesCurrent | 16,139,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,842,000 |
| 9 | ResearchAndDevelopmentExpense | 74,083,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 35,160,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 5,110,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 382,736,000 |
| 1 | Liabilities | 16,139,000 |
| 2 | Expenses | 93,925,000 |
| 3 | Revenues | 35,160,000 |
| 4 | StockholdersEquity | 366,597,000 |
| 5 | NetIncome | -58,765,000 |
| 6 | ComprehensiveNetIncome | -56,210,000 |
| 7 | BaseVar | 266,535,000 |
| 8 | EconomicCapitalRatio | 2.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
